Osmotic-controlled release oral tablets: technology and functional insights

Controlled drug delivery has taken center stage in pharmaceutical development, enhancing tolerability and patient compliance. Osmotic tablets are a special type of controlled-release dosage form that offers additional benefits. Unlike conventional controlled release, osmotic tablets are insensitive to various physiological factors that result from food intake, gastric pH, and patient-to-patient variability. The delivery strategy and release profile for this system can be customized to suit various APIs with a wide range of thermodynamic properties. Due to this uniqueness, osmotic systems have witnessed increasing interest and the number of marketed products has doubled in the past decades. Currently, there is a need for standard development that will augment drug load, improve manufacturability, optimize performance, and ultimately decrease the overall production time and product cost. In recent years, oral osmotic tablets have sparked a therapeutic paradigm for controlled-release dosage forms due to their intrinsic insensitivity to physiological and physicochemical factors. Despite these benefits, the design of an optimal osmotic technology is precluded by various challenges. These limitations include manufacturing complexity, the lack of understanding of the functional mechanics, and inadequate optimization for the desired bio-performance. This paper systematically reviews the development of an osmotic-driven drug delivery system and the strategy for a zero-order release profile with an emphasis on swellable core technology. We discuss the applicability of the various types of osmotic tablets, their suitability to specific needs, and factors that drive the technology selection. Finally, we review the challenges, opportunities, and future perspectives associated with osmotic tablets. In recent years, oral osmotic tablets have sparked a therapeutic paradigm for controlled-release dosage forms due to their intrinsic insensitivity to physiological and physicochemical factors. Despite these benefits, the design of an optimal osmotic technology is precluded by various challenges. These limitations include manufacturing complexity, the lack of understanding of the functional mechanics, and inadequate optimization for the desired bio-performance. This paper systematically reviews the development of an osmotic-driven drug delivery system and the strategy for a zero-order release profile with an emphasis on swellable core technology. We discuss the applicability of the various types of osmotic tablets, their suitability to specific needs, and factors that drive the technology selection. Finally, we review the challenges, opportunities, and future perspectives associated with osmotic tablets. the ingredient in a pharmaceutical drug product that is biologically active. It can be used interchangeably with drug molecules. the area under the curve of a plasma drug concentration versus time graph, which reflects the total drug exposure across time after administration. It is directly related to bioavailability. the biopharmaceutics classification system is a system utilized to characterize and distinguish drug molecules based on parameters such as solubility and intestinal permeability. the fraction of drug absorbed systemically and is thus available to produce a biological effect. It is determined through the quantification of ‘AUC’. the peak maximum or numerical value that indicates the maximum drug concentration in the body. It is represented as the maximum peak on a graph of drug concentration in blood plasma as a function of time. an inactive substance in drug products that serves as the vehicle or medium for drug molecules or API. the time it takes for half of the drug to be metabolized and eliminated from the body. a predictive and strategic model that estimates the relationship between an in vitro property of a dosage form and its in vivo response. an osmotically active agent in a salt form that acts to draw water from the surrounding medium through a semipermeable membrane.